News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 289–324
- Matches
- 5162
- Sources here
- 22
- Companies here
- 35
Active search
5162 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
5 Must-Read Analyst Questions From Elanco’s Q2 Earnings Call
5 Must-Read Analyst Questions From Elanco's Q2 Earnings Call Elanco's results for the second quarter were positively received by the market, reflecting momentum across both its Pet Health and Farm Animal businesses. Management attributed growth to strong execution in the U.S. and international markets, …
Guardant Health Sees Shield, MRD and Oncology Testing Growth Accelerate
Guardant Health reported accelerated growth in its oncology testing, minimal residual disease (MRD), and colorectal cancer screening businesses, with significant year-over-year increases in revenue for Guardant360 and Guardant Reveal. The company plans to launch its tumor-informed Reveal Ultra test in 2026 and expects a …
AMN Healthcare (AMN) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Randle ReecePresident and Chief Executive Officer - Caroline GraceChief Financial and Operating Officer - Brian Scott TAKEAWAYS Revenue -- $673 million, representing …
Is Tenet Healthcare (THC) Overvalued Following Higher 2026 Adjusted EPS Guidance?
Tenet Healthcare (THC) has seen a significant surge in its share price and an increase in its 2026 adjusted EPS guidance, leading to questions about its valuation. While some analysts deem it overvalued at $250 compared to its last close of $267.05, others note …
Sharemaestro market context Price below Trend Line 52 weeks +0.6% · Next-week setup positive 55.4%Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) on Behalf of Investors
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. following a whistleblower complaint. The complaint alleges accounting irregularities that artificially inflated the company's financial results, specifically Adjusted EBITDA. This news led to a significant drop in Alignment Healthcare's stock …
UnitedHealth Group stock eases as investor lawsuit spotlights governance risks
UnitedHealth Group's stock is trading below its 2024 peak, influenced by a new shareholder lawsuit alleging governance and security failures that led to billions in investor losses. Despite these legal challenges, the stock has seen a 20.8% year-to-date gain, trading near $399. The lawsuit, …
Guardant Health Insider Sold Shares Worth $7,645,218, According to a Recent SEC Filing
Terilyn J. Monroe, Chief People Officer at Guardant Health, sold 46,300 shares of the company's stock on August 12, 2026. The total value of these shares amounted to $7,645,218. This transaction was disclosed in a recent SEC filing.
Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting
Clover Health's Interim CFO, Joseph Clay Thornton, was granted 54,347 Restricted Stock Units (RSUs) of Class A Common Stock. These RSUs, valued at $0, will vest over a four-year period, with 25% vesting on August 12, 2027, and the remainder in quarterly installments, fully …
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and ACADIA Pharmaceuticals (ACAD)
J.P. Morgan analyst Chris Schott maintained a Buy rating on Elanco Animal Health (ELAN) with a consensus price target of $31.11, representing a 35.3% upside. Needham analyst Ami Fadia assigned a Buy rating to ACADIA Pharmaceuticals (ACAD) with a price target of $41.00, implying …
CVS Health (CVS) Rolls Out New PBM Tools As Employer Trust Grows
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. CVS Health (NYSE:CVS) reports that employers show higher trust in pharmacy benefit managers to …
Sharemaestro market context Trend signal active 52 weeks +39.7%Health In Tech reaffirms $45M-$50M 2026 revenue guidance while preparing HitRix launch in the second half
Earnings Call Insights: Health In Tech, Inc. (HIT) Q2 2026 MANAGEMENT VIEW * "During the second quarter, we onboarded a new carrier partner. And as part of that onboarding, the effective dates of a number of policies -- policy placements shifted into subsequent quarters." …
Sensus outlines shift to $250,000 average selling price as it targets a stronger second half
Earnings Call Insights: Sensus Healthcare (SRTS) Q2 2026 MANAGEMENT VIEW * "During the quarter, we secured equipment orders that we expected to be recognized in Q2. Third-party financing approval was not completed before June 30... which prevented us from recognizing 19 units and related …
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Announces Target Price $47
Truist Financial has reiterated its Hold rating on Omega Healthcare Investors Inc (OHI.US) and set a target price of $47 for the company's stock. This indicates that the firm believes the stock will perform in line with the market.
ALHC5941479 Bond Profile — Key Metrics
This article provides key metrics for the ALHC5941479 bond issued by Alignment Healthcare, Inc. The bond has a 4.25% coupon rate and matures on November 15, 2029. Alignment Healthcare is described as a holding company that offers customized healthcare solutions, primarily Medicare Advantage plans, …
GE HealthCare Technologies (GEHC) Stock Still Looks Cheap After A 20% Jump
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. GE HealthCare Technologies stock has climbed 19.7% over the past month, yet its valuation checks still lean toward the shares looking cheap rather …
Sharemaestro market context Price above Trend Line 52 weeks -9.1%Sensus Healthcare Q2 Adjusted Ebitda USD -3.0
This article reports that Sensus Healthcare's Q2 Adjusted EBITDA was USD -3.0. The content provided is extremely minimal, offering only this single financial data point.
Kaplan Fox is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating Hims & Hers Health, Inc. (NYSE: HIMS) for potential securities law violations. This investigation follows a lawsuit filed by the FTC and California/Utah authorities alleging that Hims & Hers failed to clearly disclose prescription charges, made it …
DaVita HealthCare Partners Inc (DVA) suffers steep weekly drop on heavy turnover
The dialysis-center operator’s 52-week weekly chart now shows short-term damage outweighing a still-active trend reading.
Is Elevance Health (ELV) Still A Bargain After A 38% Gain?
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Elevance Health has delivered a 37.6% gain over the past year, yet current valuation checks still lean on the side of the stock …
Sharemaestro market context Trend signal active 52 weeks +10.5% · Next-week setup negative 25.9%Kaplan Fox Urges Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Contact the Firm Regarding a Securities Investigation
Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of "accounting irregularities" that "artificially inflated" the company's reported financial results. A whistleblower complaint claims that operating expenses were systematically misclassified as capital expenditures. This news …
Zepp Health (ZEPP) holders Millennium and Israel Englander report 0% ownership
Millennium Management LLC, Israel A. Englander, and related entities have filed an amended Schedule 13G/A for Zepp Health Corporation (ZEPP), reporting 0% beneficial ownership of Class A Ordinary Shares. This indicates they no longer hold a significant stake in the company, with no sole …
Sensus Healthcare Q2 EPS $(0.53) misses estimate; sales fall 69%
Sensus Healthcare reported a significant decline in Q2 2026 revenue, falling 69% year-over-year to $2.3 million, missing analyst estimates. The company's net loss widened to $8.7 million, or $0.53 per share, primarily due to lower unit sales and delayed revenue recognition, along with a …
Health Catalyst (HCAT) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Senior Vice President of Finance and Investor Relations - Stephanie St. ClairChief Executive Officer - Benjamin AlbertChief Financial Officer - Jason Alger TAKEAWAYS Total Revenue -- $70.5 million, …
SANUWAVE (SNWV) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Friday, Aug. 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Morgan FrankChief Financial Officer - Peter Sorensen TAKEAWAYS Revenue -- $9.7 million, a 3% decrease from $10.1 million, reflecting a sharp decline …
MDXH Looks 79.0% Undervalued on GF Value™ but Faces Value Trap Warning
MDxHealth SA (MDXH) is currently trading at a significant discount to its GF Value, suggesting a 79.0% undervaluation. However, investors are cautioned due to the company's unprofitability, negative cash flow, and a low GF Score™ of 49/100, indicating financial weakness despite strong growth metrics. …
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.41 EPS
Sensus Healthcare (NASDAQ:SRTS) announced its quarterly earnings, reporting a significant miss on both EPS and revenue expectations. The company posted a loss of $0.53 per share against an anticipated loss of $0.12, and revenue of $2.29 million, well below the $4.60 million estimate. Despite …
American Healthcare REIT (AHR) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Friday, Aug. 7, 2026 at 1:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations and Finance - Alan Peterson Chairman and Chief Executive Officer - Jeff Hanson President and Chief Operating Officer - Gabe Willhite Chief Investment …
Omada Health (OMDA) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Vice President and Chief Accounting Officer - Craig Gracey Co-founder and Chief Executive Officer - Sean Duffy President - Wei-Li Shao Chief Financial Officer - Steve Cook Full …
UnitedHealth Group (UNH) officer uses 233 shares to cover equity-related costs
UnitedHealth Group's Chief Accounting Officer, Dennis Andrew Stankiewicz, reported a Form 4 transaction where 233.402 shares of common stock were delivered or withheld at $402.19 per share to cover equity-related costs or tax liability. Following this transaction, Stankiewicz directly holds 10,057.567 shares, which include …